NCT03100019View on ClinicalTrials.gov

Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans.

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 13, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Hypoxia, Brain
Interventions
DIETARY_SUPPLEMENT

Resveratrol

DRUG

Placebo

All Listed Sponsors
lead

Northumbria University

OTHER

NCT03100019 - Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans. | Biotech Hunter | Biotech Hunter